Concept information
Preferred term
Ipilimumab
Type
-
Topical Descriptor
Broader concept
Entry terms
- Anti CTLA 4 MAb Ipilimumab
- Anti-CTLA-4 MAb Ipilimumab
- Ipilimumab, Anti-CTLA-4 MAb
Scope note
- An anti-CTLA-4 ANTIGEN monoclonal antibody initially indicated for the treatment of certain types of metastatic MELANOMA. Its mode of actions may include blocking of CTLA-4 mediated inhibition of CYTOTOXIC T LYMPHOCYTES, allowing for more efficient destruction of target tumor cells.
History note
- 2018(2012)
In other languages
-
Finnish
-
Swedish
-
Yervoy
URI
http://www.yso.fi/onto/mesh/D000074324
{{label}}
{{#each values }} {{! loop through ConceptPropertyValue objects }}
{{#if prefLabel }}
{{/if}}
{{/each}}
{{#if notation }}{{ notation }} {{/if}}{{ prefLabel }}
{{#ifDifferentLabelLang lang }} ({{ lang }}){{/ifDifferentLabelLang}}
{{#if vocabName }}
{{ vocabName }}
{{/if}}